MetLife Payables For Collateral Under Securities Loaned And Other Transactions increased by 6.1% to $18.16B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.1%, from $17.44B to $18.16B. Over 5 years (FY 2020 to FY 2025), Payables For Collateral Under Securities Loaned And Other Transactions shows a downward trend with a -10.3% CAGR.
An increase indicates higher activity in securities lending, which can be a source of incremental investment income.
Obligations to return collateral received from counterparties in securities lending transactions. This liability is offs...
Common among large institutional investors and insurers; benchmarked against total investment assets.
non_current_liabilities_payables_for_collateral_under_se_10f124| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $30.62B | $31.38B | $31.92B | $30.48B | $23.82B | $24.89B | $20.94B | $19.86B | $18.81B | $17.80B | $17.52B | $17.47B | $17.72B | $17.13B | $17.13B | $17.44B | $17.15B | $17.14B | $17.12B | $18.16B |
| QoQ Change | — | +2.5% | +1.7% | -4.5% | -21.9% | +4.5% | -15.9% | -5.1% | -5.3% | -5.4% | -1.5% | -0.3% | +1.4% | -3.3% | -0.0% | +1.8% | -1.7% | -0.0% | -0.1% | +6.1% |
| YoY Change | — | — | — | — | -22.2% | -20.7% | -34.4% | -34.8% | -21.0% | -28.5% | -16.3% | -12.0% | -5.8% | -3.7% | -2.3% | -0.2% | -3.2% | +0.0% | -0.1% | +4.1% |